• About Us
  • Business Areas
  • R & D
  • Manufacturing
  • Beyond Business
  • Investors
  • Careers
  • Contact Us

Investors

Investors > FY 2012-13

    • Overview
    • Chairman's Statement
    • Shareholder Information
    • Policies or Statutory Documents
    • IEPF
    • Debentures
    • Amalgamation
    • MOA/AOA
    • Procedure for Dematerialisation of Shares
    • Archives
    • Credit Ratings
    • CSR
    • AGM Transcript
    • Annual Return
  • Financial
    • 2022-23
    • 2021-22
    • 2020-21
    • 2019-20
    • 2018-19
    • 2017-18
    • 2016-17
    • 2015-16
    • 2014-15
    • 2013-14
    • 2012-13
    • 2011-12

Investors > FY 2012-13



1. Annual Report

Annual Report

2. Intimation to Stock Exchange

Shareholding Pattern Q4
Shareholding Pattern Q3
Shareholding Pattern Q2
Shareholding Pattern Q1
Quarterly Compliance Report Q4
Quarterly Compliance Report Q3
Quarterly Compliance Report Q2
Quarterly Compliance Report Q1

3. Quarterly Results

  • Q1 12-13
  • Q2 12-13
  • Q3 12-13
  • Q4 12-13
Press Release on Q1 Results
Investors Presentation
Q1, FY 2013 Con call Transcript
Stand Alone Results
Consolidated Results
Press Release on Q2 Results
Investors Presentation
Q2, FY 2013 Con call Transcript
Stand Alone Results
Consolidated Results
Press Release on Q3 Results
Investors Presentation
Q3, FY 2013 Con call Transcript
Stand Alone Results
Consolidated Results
Press Release on Q4 Results
Investors Presentation
Q4, FY 2013 Con call Transcript
Q4, FY 2013 Con call Transcript
Stand Alone Results
Consolidated Results

Details of Nodal Officer

Name : Mahesh Agrawal

Designation : VP (Legal) & Company Secretary

E-mail Id : investorservices@torrentpharma.com

IEPF Authority - Refund web page

IEPF Authority - Refund web page >>

Torrent Pharmaceuticals Ltd. © Copyright 2017
Privacy Policy | Disclaimer | Site Map